Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: Implications for further preclinical drug development

Molecular Pharmacology

Volumn 74, Issue 2, 2008, Pages 330-337

  François, Katrien O ^a   Auwerx, Joeri ^a   Schols, Dominique ^a   Balzarini, Jan ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; CARBOHYDRATE BINDING PROTEIN; ENVELOPE PROTEIN; GALANTHUS NIVALIS EXTRACT; GLYCAN; GLYCOPROTEIN GP 120; HIPPEASTRUM EXTRACT; INTERCELLULAR ADHESION MOLECULE 3; PLANT EXTRACT; PLANT LECTIN; PRADIMICIN A; URTICA DIOICA EXTRACT;

ANTIVIRAL RESISTANCE; ARTICLE; CELL CULTURE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS RESISTANCE; DENDRITIC CELL; DRUG ACTIVITY; DRUG SENSITIVITY; GALANTHUS NIVALIS; GENE DELETION; GIANT CELL; HIPPEASTRUM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFECTION PREVENTION; MEDICINAL PLANT; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; URTICA DIOICA; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; ANTHRACYCLINES; ANTIVIRAL AGENTS; BINDING SITES; CARBOHYDRATE METABOLISM; CELLS, CULTURED; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, VIRAL; HIV; HUMANS; PLANT LECTINS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 47949093805     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.047621     Document Type: Article

References (37)

1. Balzarini J (2005) Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect Dis 5:726-731.
2. Balzarini J (2006) Inhibition of HIV entry by carbohydrate-binding proteins. Antiviral Research 71:237-247.
3. Balzarini J (2007) Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol 5:583-597.
4. Balzarini J, Naesens L, Slachmuylders J, Niphuis H, Rosenberg I, Holy A, Schellekens H, and Declercq E (1991) 9-(2-Phosphonylmethoxyethyl)adenine (Pmea) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus-infection in rhesus-monkeys. AIDS 5:21-28.
5. Balzarini J and Van Damme L (2007) Microbicide drug candidates to prevent HIV infection. Lancet 369:787-797.
6. Balzarini J, Van Herrewege Y, Vermeire K, Vanham G, and Schols D (2007a) Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes. Mol Pharmacol 71:3-11.
7. Balzarini J, Van Laethem K, Daelemans D, Hatse S, Bugatti A, Rusnati M, Igarashi Y, Oki T, and Schols D (2007b) Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus. J Virol 81:362-373.
8. Balzarini J, Van Laethem K, Hatse S, Froeyen M, Peumans W, Van Damme E, and Schols D (2005) Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the Achilles heel of HIV. J Biol Chem 280:41005-41014.
9. Balzarini J, Van Laethem K, Hatse S, Vermeire K, De Clercq E, Peumans W, Van Damme E, Vandamme AM, Bolmstedt A, and Schols D (2004) Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins. J Virol 78: 10617-10627.
10. Berger EA, Murphy PM, and Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657-700.
11. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, and Harrison SC (2005a) Determining the structure of an unliganded and fully glycosylated SIV gp 120 envelope glycoprotein. Structure 13:197-211.
12. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, and Harrison SC (2005b). Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433:834-841.
13. Chen Z, Zhou P, Ho DD, Landau NR, and Marx PA (1997) Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 71:2705-2714.
14. Dairi T, Hamano Y, Igarashi Y, Furumai T, and Oki T (1997) Cloning and nucleotide sequence of the putative polyketide synthase genes for pradimicin biosynthesis from Actinomadura hibisca. Biosci Biotechnol Biochem 61:1445-1453.
15. Edinger AL, Amedee A, Miller K, Doranz BJ, Endres M, Sharron M, Samson M, Lu ZH, Clements JE, MurpheyCorb M, et al. (1997) Differential utilization of CCRS by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A 94:4005-4010.
16. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, et al. (2000a) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597.
17. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, and Figdor CG (2000b) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575-585.
18. Kilby JM, Hopkins S, Venetta TM, DiMassimo B, Cloud GA, Lee JY, Alldredge L, Hunter E, Lambert D, Bolognesi D, et al. (1998) Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 4:1302-1307.
19. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, and Hendrickson WA (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
20. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, and Gregory TJ (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265:10373-10382.
21. Marcon L, Choe H, Martin KA, Farzan M, Ponath PD, Wu LJ, Newman W, Gerard N, Gerard C, and Sodroski J (1997) Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIV-(mac)239. J Virol 71:2522-2527.
22. Marx PA and Chen Z (1998) The function of simian chemokine receptors in the replication of SIV. Semin Immunol 10:215-223.
23. Ohgimoto S, Shioda T, Mori K, Nakayama EE, Hu H, and Nagai Y (1998) Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity. J Virol 72:8365-8370.
24. Pöhlmann S, Baribaud F, Lee B, Leslie GJ, Sanchez MD, Hiebenthal-Millow K, Munch J, Kirchhoff F, and Doms RW (2001) DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J Virol 75:4664-4672.
25. Pöhlmann S and Doms RW (2002) Evaluation of current approaches to inhibit HIV entry. Curr Drug Targets Infect Disord 2:9-16.
26. Princen K, Hatse S, Vermeire K, De Clercq E, and Schols D (2004) Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists. Retrovirology 1:2.
27. Reitter JN, Means RE, and Desrosiers RC (1998) A role for carbohydrates in immune evasion in AIDS. Nat Med 4:679-684.
28. Schols D, Pauwels R, Desmyter J, and De Clercq E (1990) Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 175:556-561.
29. Skinner MA, Ting R, Langlois AJ, Weinhold KJ, Lyerly HK, Javaherian K, and Matthews TJ (1988) Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res Hum Retroviruses 4:187-197.
30. Tsai CC, Emau P, Jiang YH, Agy MB, Shattock RJ, Schmidt A, Morton WR, Gustafson KR, and Boyd MR (2004) Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res Hum Retroviruses 20:11-18.
31. Ueki T, Oka M, Fukagawa Y, and Oki T (1993) Studies on the mode of antifungal action of pradimicin antibiotics. III. Spectrophotometric sequence analysis of the ternary complex formation of BMY-28864 with D- mannopyranoside and calcium. J Antibiot (Tokyo) 46:465-477.
32. Van Damme EJ, Allen AK, and Peumans WJ (1988a) Related mannose-specific lectins from different species of the family Amaryllidaceae. Physiol Plant 73:52-57.
33. Van Damme EJ, Broekaert WF, and Peumans WJ (1988b) The urtica-dioica agglu-tinin is a complex mixture of isolectins. Plant Physiology 86:598-601.
34. Van Rompay KK (2005) Antiretroviral studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments. AIDS Rev 7:67-83.
35. Veazey RS, Klasse PJ, Schader SM, Hu Q, Ketas TJ, Lu M, Marx PA, Dufour J, Colonno RJ, Shattock RJ, et al. (2005) Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438:99-102.
36. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, et al. (2003) Antibody neutralization and escape by HIV-1. Nature 422:307-312.
37. Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, Hendrickson WA, and Sodroski JG (1998) The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.